Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy
Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…
Read more
Named profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma
Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…
Read more
Appetite Support: Find and Treat the Reason a Dog Is Not Eating
Reduced appetite can result from nausea, pain, fever, constipation, oral disease, swallowing difficulty, medication effects, tumor location, stress, or metabolic illness. Appetite support starts by investigating and treating…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read more
Urinalysis and Urine Culture in the Oncology Patient
Urine testing can assess concentration, blood, protein, sediment, and infection questions that matter before or during cancer treatment.
Read more
Cardiac Assessment Around Potentially Cardiotoxic Cancer Therapy
Selected cancer drugs, tumors, symptoms, and comorbidities can make a cardiovascular baseline or follow-up relevant to treatment safety.
Read more
Mirtazapine for Appetite Support: Nausea-First and Interaction Boundary
Mirtazapine may support appetite in selected dogs or cats, but nausea, pain, obstruction, oral disease, diet, organ function, and serotonergic interactions need attention first.
Read more
Capromorelin for Appetite Support: Cause, Species, and Monitoring
Capromorelin is a ghrelin-receptor agonist used in species- and product-specific veterinary appetite settings; it does not replace evaluation of why intake fell.
Read more
Oral Mucositis and Mouth-Pain Support During Cancer Treatment
Painful oral inflammation or ulceration can interfere with eating, drinking, grooming, and medication and requires examination of treatment effects, infection, tumor, dental disease, and trauma.
Read more
Turmeric and Curcumin: Bioavailability, Interaction, and Evidence Limits
Turmeric and curcumin products vary in extract, concentration, absorption enhancers, and purity, while robust canine cancer outcome evidence is lacking.
Read more
CBD and Cannabis Products in Pets With Cancer: Regulatory and Safety Boundary
FDA has not approved CBD for animal use, and product quality, THC contamination, interactions, liver effects, sedation, legal status, and cancer claims require caution.
Read more
Chinese Herbal Formulas: Identification, Quality, and Evidence Review
A named traditional formula can vary by translation, ingredient, species, processing, manufacturer, and practitioner modification, so exact identification comes before benefit or safety claims.
Read more